AACR 2022 mini-symposium

EMPIRI's co-founder Dr. Kyuson Yun will be presenting at the AACR, mini-symposium session "Ex Vivo Models for Understanding Genetic Variation, Metastasis, and Treatment Sensitivity" on our platform technology, "E-slice: A novel 3D culture platform for precision medicine". #medicine #technology #culture #precisionmedicine #precisiononcology #cancerdiagnostics #aacr #drugdevelopment #drugdiscovery #pharmaceutical